Cheaper, quicker kit can help in scaling up testing: Researcher

India’s first diagnostic kit for Covid-19 based on the gene editing technology CRISPR Cas9 has been approved for commercial use by the Drug Controller General of India. The kit was found to have high sensitivity of 96% and specificity of 98%, meaning it can accurately detect both positive and negative cases

from Hindustan Times - india https://ift.tt/32NxrgW

Share: